Eradication
As the number of new cases continues to dwindle, one of the most important questions for the future is whether SARS can be eliminated or eradicated from its new human host. Experience with many other infectious diseases, including smallpox and poliomyelitis, has demonstrated that complete eradication of an infectious disease is possible only when three precise requirements can be met (WHO Update 84):
1)An effective intervention capable of interrupting transmission – ideally, a vaccine – must be available.
2)Easy-to-use diagnostic tools are needed, with sufficient sensitivity and specificity to detect levels of infection that can lead to transmission of the disease.
3)Finally, infection of humans must be essential to the life-cycle of the causative agent – if the chain of human-to-human transmission is broken, the agent cannot survive. Existence of an animal reservoir greatly complicates eradication, but does not preclude it, provided that interventions exist to break the chain of transmission in the animal species as well.
To achieve eradication at the global level, the control intervention must be safe, simple, and affordable. Current control measures for SARS, including case detection and isolation, tracing and follow-up of contacts, and quarantine, are effective but extremely time-intensive, costly, and socially disruptive. Few, if any, countries can sustain such efforts over time (WHO Update 84).
- April 8-10
- April 12
- June 6
- August 14
- September 8
- September 24
- References
- 30 Virology
- Discovery of the SARS Virus
- Initial Research
- Coronaviridae
- SARS Co-V
- Genome Sequence
- Antiviral Agents and Vaccines
- Antiviral Drugs
- Vaccines
- Outlook
- References
- Routes of Transmission
- Patient Factors in Transmission
- Asymptomatic Patients
- Symptomatic Patients
- The Unsuspected Patients
- High-Risk Activities
- Transmission during Quarantine
- Introduction
- Global Spread
- Hong Kong
- Other Countries
- Eradication
- Outlook
- Introduction
- International Coordination
- Management of SARS in the post-outbreak period
- National Measures
- Legislation
- Quarantine after Discharge
- Infection Control in Healthcare Settings
- General Measures
- Protective Measures
- Special Settings
- Intensive Care Units
- Intubating a SARS Patient
- Anesthesia
- Triage
- Internet Sources
- After the Outbreak
- Conclusion
- 108 Case Definition
- WHO Case Definition
- Suspect case
- Reclassification of cases
- CDC Case Definition
- 112 Diagnostic Tests
- Introduction
- Laboratory tests
- Virus isolation
- Antibody detection
- Interpretation
- Limitations
- Biosafety considerations
- Clinical Presentation and Diagnosis
- Clinical Presentation
- Diagnosis
- Clinical Course
- Histopathology
- Lung Biopsy
- Postmortem Findings
- Discharge and Follow-up
- Psychosocial Issues
- References
- 144 SARS Treatment
- Antibiotic therapy
- Antiviral therapy
- Ribavirin
- Alternative medicine
- Immunomodulatory therapy
- Other immunomodulators
- Assisted ventilation
- Invasive mechanical ventilation
- Clinical outcomes
- Appendix 1
- A standardized treatment protocol for adult SARS in Hong Kong
- Appendix 2
- A treatment regimen for SARS in Guangzhou, China
- References
- 168 Pediatric SARS
- Clinical Manifestation